Travere Therapeutics Inc

Затворен

56.64 0.57

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

55.56

Максимум

56.88

Ключови измерители

By Trading Economics

Приходи

-15M

-37M

Продажби

-2.5M

127M

EPS

-0.4

Марж на печалбата

-28.775

Служители

497

EBITDA

-8.6M

-9.2M

Препоръки

By TipRanks

Препоръки

Силна покупка

12-месечна прогноза

+2.48% upside

Дивиденти

By Acuity

Следващи печалби

5.08.2026 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

1.7B

5.4B

Предишно отваряне

56.07

Предишно затваряне

56.64

Travere Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.07.2026 г., 23:51 ч. UTC

Bitcoin and Ethereum rise as weak U.S. jobs data dims Fed rate hike expectations, while Asian markets react positively to easing geopolitical tensions.

5.07.2026 г., 23:51 ч. UTC

Bitcoin and Ethereum see positive returns amid weak U.S. jobs data and stable Eurozone activity, while geopolitical tensions ease.

5.07.2026 г., 23:51 ч. UTC

Bitcoin and Ethereum rise as U.S. jobs data dims Fed rate hike expectations ahead of key FOMC minutes release.

5.07.2026 г., 23:51 ч. UTC

Disappointing U.S. jobs report dampens interest rate hike expectations, impacting investor sentiment and market stability ahead of key economic releases.

5.07.2026 г., 23:51 ч. UTC

ISM Services PMI Forecasted at 54.2 Indicates Continued Growth Amid Economic Uncertainties and Potential Fed Policy Shifts

5.07.2026 г., 23:51 ч. UTC

Correlated Moves

Bitcoin is trading higher during Sunday’s session, continuing its upward trajectory since Saturday's close. The asset remains above its 20-day moving average.

5.07.2026 г., 23:41 ч. UTC

Canada's Full-Time Employment Change Data Release on July 10 Sparks Market Focus Amid Economic Uncertainty and Government Initiatives.

5.07.2026 г., 23:41 ч. UTC

Canada's Part-Time Employment Change Data Release on July 10, 2026, Could Signal Economic Health Amid Government Policy Announcements.

5.07.2026 г., 23:41 ч. UTC

Canada's unemployment rate data release on July 10, 2026, expected to show slight improvement at 6.6%, amid mixed signals in job growth and inflation concerns impacting monetary policy.

5.07.2026 г., 23:41 ч. UTC

Canada's Employment Change Report Forecasts 10,000 Job Increase Amid Mixed Market Sentiment and Economic Challenges

5.07.2026 г., 23:41 ч. UTC

Canada's Labor Force Participation Rate Release Amid Growing Concerns Over Job Security Due to AI and Automation

5.07.2026 г., 23:31 ч. UTC

Macro News
Correlated Moves

Silver prices are rising, supported by a recovery in gold and recent oil supply increases. The U.S. dollar's strength may limit upward momentum.

5.07.2026 г., 23:31 ч. UTC

Correlated Moves

XRP is trading roughly flat amid broader market sentiment, with Bitcoin moving moderately. The cumulative price change since Saturday remains minimal.

5.07.2026 г., 23:22 ч. UTC

U.S. Exports Data Release on July 7, 2026, Expected to Reflect Strong Performance Amid Trade Tensions and Inflationary Pressures

5.07.2026 г., 23:22 ч. UTC

U.S. Balance of Trade report on July 7 forecasts a $78.8 billion deficit, raising concerns over persistent trade imbalances and potential impacts on monetary policy amid cautious market sentiment.

5.07.2026 г., 23:22 ч. UTC

U.S. Imports Data Release on July 7 Expected to Show Continued Growth Amid Tariff Impacts and Supply Chain Adjustments

5.07.2026 г., 23:22 ч. UTC

Brazil's July 10 inflation rate release draws market attention amid global economic concerns and potential volatility.

5.07.2026 г., 23:22 ч. UTC

Mexico's July Inflation Rate Release Expected to Show Stabilization Around 3.94%, Influencing Future Banxico Policy Decisions

5.07.2026 г., 23:22 ч. UTC

Brazil's June Inflation Rate Expected to Rise, Heightening Market Volatility Ahead of July 10 Release

5.07.2026 г., 23:22 ч. UTC

Mexico's June Inflation Rate Release on July 9 Expected to Influence Monetary Policy Amid Global Economic Concerns.

5.07.2026 г., 23:22 ч. UTC

Canada's Balance of Trade data set for July 7, 2026, anticipates a C$2.4 billion surplus amid strong export activity and cautious optimism despite global uncertainties.

5.07.2026 г., 23:11 ч. UTC

USD/HKD is trading roughly flat after-market, with no specific news identified. Anticipation surrounds upcoming FOMC minutes and inflation data.

5.07.2026 г., 23:02 ч. UTC

Macro News
Correlated Moves

The U.S. dollar has recovered against the Canadian dollar, leading to a slight gain in USD/CAD after-market trading.

5.07.2026 г., 23:02 ч. UTC

Gold and silver are trading lower during Sunday’s session, continuing a downward trend since Friday's close. Market participants await key economic data.

5.07.2026 г., 23:01 ч. UTC

Correlated Moves

Silver/AUD is trading higher, supported by gold's gains and reduced interest rate hike expectations following weaker job growth data.

5.07.2026 г., 23:01 ч. UTC

Correlated Moves

Gold/NZD is trading higher, supported by rising gold prices against the U.S. dollar and market volatility ahead of key economic data releases.

5.07.2026 г., 23:01 ч. UTC

Correlated Moves

Silver/GBP is trading higher, reflecting gains in gold prices. The recent trend includes four consecutive sessions of closing higher.

5.07.2026 г., 23:01 ч. UTC

Correlated Moves

Silver/CHF is trading higher, reflecting gains from correlated movements in gold. The upward trend continues after four consecutive sessions of increases.

5.07.2026 г., 23:01 ч. UTC

Correlated Moves

Gold/HKD is higher, supported by positive market sentiment and a rise in silver. Weaker job growth data has reduced expectations for immediate interest rate hikes.

5.07.2026 г., 23:01 ч. UTC

Correlated Moves

Silver/CAD is higher, reflecting gains alongside rising gold prices. The asset has seen four consecutive sessions of higher closes amid significant volatility.

Сравнение с други в отрасъла

Ценова промяна

Travere Therapeutics Inc Прогноза

Ценова цел

By TipRanks

2.48% нагоре

12-месечна прогноза

Среден 58.33 USD  2.48%

Висок 70 USD

Нисък 43 USD

Според 12 анализатори от Wall Street, предложили 12-месечна ценова цел за Travere Therapeutics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

12 ratings

11

Купи

1

Задържане

0

Продай

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Travere Therapeutics Inc

Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases. Its products include FILSPARI (sparsentan), a once-daily, oral medication designed to target two critical pathways in the disease progression of IgA Nephropathy (endothelin 1 and angiotensin-II); and Thiola and Thiola EC (tiopronin tablets) for the treatment of cystinuria, a rare genetic cystine transport disorder that causes high cystine levels in the urine and the formation of recurring kidney stones. The company's clinical-stage programs consist of Sparsentan, a novel investigational product candidate, which has been granted Orphan Drug Designation for the treatment of focal segmental glomerulosclerosis in the U.S. and Europe; and Pegtibatinase (TVT-058), a novel investigational human enzyme replacement candidate being evaluated for the treatment of classical homocystinuria. It has a cooperative research and development agreement with National Institutes of Health's National Center for Advancing Translational Sciences and Alagille Syndrome Alliance for the identification of potential small molecule therapeutics for Alagille syndrome. The company was formerly known as Retrophin, Inc. and changed its name to Travere Therapeutics, Inc. in November 2020. Travere Therapeutics, Inc. was incorporated in 2008 and is headquartered in San Diego, California.
help-icon Live chat